Arixtra
NDC Package 54868-5652-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Arixtra is fondaparinux is used to treat serious blood clots in the legs and/or lungs. Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-5652 and is authorized under FDA application NDA021345.

Identification & Billing

NDC Package Code
54868-5652-0
Package Description
10 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE
Product Code
54868-5652
11-Digit Billing Format
54868565200
RxNorm Crosswalk
  • RxCUI: 861363 - fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe
  • RxCUI: 861363 - 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe
  • RxCUI: 861363 - fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe
  • RxCUI: 861364 - Atrixtra 5 MG in 0.4 ML Prefilled Syringe
  • RxCUI: 861364 - 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]

Clinical Specifications

Proprietary Name
Arixtra
Dosage Form
-
Usage Information
Fondaparinux is used to treat serious blood clots in the legs and/or lungs. It is usually used with another "blood thinner" medication (warfarin). If untreated, blood clots can travel to the lungs, heart, or brain, causing serious (possibly fatal) breathing problems, heart attack, or stroke. This drug may also be used to prevent blood clots after certain surgeries with an increased risk of blood clots (such as hip fracture, abdominal, knee/hip replacement). Fondaparinux is known as a "blood thinner" (anticoagulant). It is a drug similar to heparin that works by blocking certain natural substances in the blood that cause clotting.

Regulatory & Marketing

Labeler Name
Physicians Total Care, Inc.
FDA Application #
NDA021345
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-07-2001
End Marketing Date
06-30-2011
Listing Expiration
06-30-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54868-5652-0 identifies a specific commercial package of 10 syringe in 1 carton / .4 ml in 1 syringe of Arixtra, labeled by Physicians Total Care, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on December 07, 2001. The current certification is valid through June 30, 2011.

What are the primary indications for this medication?

Fondaparinux is used to treat serious blood clots in the legs and/or lungs. It is usually used with another "blood thinner" medication (warfarin). If untreated, blood clots can travel to the lungs, heart, or brain, causing serious (possibly fatal) breathing problems, heart attack, or stroke. This drug may also be used to prevent blood clots after certain surgeries with an increased risk of blood clots (such as hip fracture, abdominal, knee/hip replacement). Fondaparinux is known as a "blood thinner" (anticoagulant). It is a drug similar to heparin that works by blocking certain natural substances in the blood that cause clotting.

How is this Physicians Total Care, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868565200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
54868-5652-0
11-Digit CMS (5-4-2)
54868-5652-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.